ARTICLE
30 March 2026

ACCESS Granted: Outcome And Value-Based CMS Model For Digital Health Management

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
The CMS aims to expand digital health technology usage among Medicare beneficiaries and providers under its new ACCESS Model, where payment is tied to beneficiaries achieving measurable clinical outcomes.
United States Food, Drugs, Healthcare, Life Sciences
Alexis S. Gilroy’s articles from Jones Day are most popular:
  • with readers working within the Oil & Gas industries

The Centers for Medicare & Medicaid Services ("CMS") aims to expand digital health technology usage among Medicare beneficiaries and providers under its new Advancing Chronic Care with Effective, Scalable Solutions ("ACCESS") Model, where payment is tied to beneficiaries achieving measurable clinical outcomes.

To incentivize the growth of technology-enabled chronic condition management, CMS recently announced the ACCESS Model, which tests Outcome-Aligned Payments ("OAP")—fixed per-beneficiary payments where full payment is contingent on beneficiaries achieving measurable clinical outcomes. CMS will accept ACCESS Model applications through this Participant Portal beginning in 2026, with rolling admissions through early 2033. To participate in the first cohort, which begins July 5, 2026, applications are due April 1, 2026.

Key Features

  • Duration: July 5, 2026 – June 30, 2036
  • Eligible Participants: Medicare Part B-enrolled providers or suppliers (excluding Durable Medical Equipment, Prosthetics, Orthotics, and Supplies, or DMEPOS, and laboratory suppliers). Note: Interested digital health tech companies that are not Part B-enrolled providers may partner with eligible providers to deliver services.
  • Eligible Beneficiaries: Original Medicare beneficiaries (i.e., fee-for-service, non-Medicare Advantage) who have qualifying chronic conditions included in one of the "Clinical Tracks" below:
    • Early Cardio-Kidney-Metabolic. Hypertension, or at least two of dyslipidemia, obesity or overweight with marker of central obesity, or prediabetes.
    • Cardio-Kidney-Metabolic. Diabetes mellitus, chronic kidney disease, or atherosclerotic cardiovascular disease.
    • Musculoskeletal. Chronic musculoskeletal pain.
    • Behavioral Health. Depression or anxiety.
  • Eligible Technologies: Food and Drug Administration-compliant digital health tools, connected devices, and software and digital health devices participating in the TEMPO Pilot.
  • Payment: Depending on the Clinical Track and other factors, the annual payment-per-beneficiary ranges from $90 to $420. Fifty percent of this payment is distributed in equal monthly installments. The remaining 50% is withheld until year-end. Participants may recover up to the full withheld amount if at least half of their beneficiaries meet the required clinical outcome target.
  • Medicare Fee-For-Service ("FFS") Exclusion: ACCESS participants and their affiliated entities may not submit FFS claims for aligned beneficiaries during active care periods.
  • CMS Program Overlap: ACCESS participants may participate in, and ACCESS beneficiaries may be attributed to, other CMS models, including, without limitation, managed security service providers and the upcoming LEAD Model. CMS is evaluating a temporary exclusion of ACCESS spending from accountable care organization financial benchmarks and reconciliation during the first year of ACCESS, before incorporating related spending into total cost-of-care calculations in later years.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More